Examination Report |
1 | TM-1 | 02 Jun 2010 |
10 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 12 Apr 2022 |
11 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 09 Feb 2023 |
12 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 17 Aug 2023 |
13 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 16 Jan 2024 |
14 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 25 Jun 2024 |
15 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 22 Nov 2024 |
2 | TM-16 | 23 Feb 2011 |
3 | Letters related to TOP | 20 Apr 2015 |
4 | TM-16 | 08 Feb 2017 |
5 | Letters related to TOP | 24 Jul 2019 |
6 | Letters related to TOP | 13 Jan 2020 |
7 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 07 Aug 2020 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 15 Feb 2021 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Aug 2021 |
The application for Nicobolin was made on 02 June 2010.
The trademark applicant for Nicobolin is ABBOTT HEALTHCARE.
Nicobolin is applied in class(es) 5.
Application for Nicobolin is on Opposed stage.
Application Id allotted to Nicobolin is 1974208.
Trademark agent or attorney for the application is Zeusip.
Nicobolin filed with the Intellectual property office as a WORD.